Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who meet criteria for tympanoplasty procedure~* Willing to comply with the protocol and attend all study visits~* Able to provide written informed consent~Exclusion Criteria:~* Patients who have previously undergone middle ear or lateral skull base surgery~* Patients who would not qualify for a tympanoplasty~* Any type of platelet disorder, cancer, or ongoing systemic infection~* Any type of hemodynamic instability, septicemia, infection, tobacco use, any use of steroids to the ear drums~* Type I diabetes or other autoimmune pathology

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PRP Treatment (Type: EXPERIMENTAL): Participants receive platelet rich plasma treatment. Participants will be asked to make up to 5 trips to the clinic (one for eligibility, one for the PRP, three follow-up visits). Participation is expected to last up to about 6 weeks. After the second visit and application of PRP, patients will be monitored closely for any complications or concerns. This will include a follow up phone call 3-5 days after the initial application of PRP. Patients will also be followed closely in 2 week intervals or sooner should any problems or concerns arise.

Based on this trial design, predict the completion outcome and termination type (if applicable).